Skip to main content
Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy
ABBV logo

NYSE · HEALTHCARE · Earnings & dividends

AbbVie Inc earnings and payout view.

Next scheduled report in 58 days, last quarterly EPS, consensus estimates, payout status, and capital-return context for ABBV.

Next report
July 30, 2026
58 days · time TBD
EPS (TTM)
$2.05
Latest reported EPS
$2.65
Consensus: $2.67
Last EPS surprise
-0.7%
Miss · $2.65 actual vs $2.67 est.
EPS History & Surprise
PeriodActual EPSEst. EPSSurprise
Q4$0.98$0.99-1.4%
Q1$0.68$0.67+1.5%
Q2$0.82$0.79+3.8%
Q3$0.82$0.77+6.5%
Q4$0.82$0.82+0.0%
Q1$0.71$0.68+4.4%
Q2$0.82$0.76+7.9%
Q3$0.89$0.77+15.6%

Most recent periods shown. Full history available via data providers.

Dividends and capital return

Payout status beside the earnings base.

Dividend yield only makes sense next to earnings power. TECHi keeps payout ratio, yield, and ex-date on this page so income investors can read the cash return against EPS.

Forward yield
3.08%
Annual payout
$6.74 per share
Payout ratio
329% of EPS
Stretched - exceeding earnings
Ex-dividend date
April 15, 2026
Hold by this date for the next payout

EPS beat history

ABBV has 5 beats in the last 6 reported quarters.

Recent reported quarters are compared against the consensus estimate so the latest print is easy to read at a glance. Positive bars mean reported EPS cleared expectations; negative bars mark misses.

Last actual EPS
$2.65
Q1 FY2026
Last estimate
$2.67
April 29, 2026
Surprise amount
-$0.02

Recent quarters

Q1 FY2026-0.7%

$2.65 actual vs $2.67 est.

Q4 FY2025+2.3%

$2.71 actual vs $2.65 est.

Q3 FY2025+4.5%

$1.86 actual vs $1.78 est.

Q2 FY2025+2.1%

$2.97 actual vs $2.91 est.

Q1 FY2025+2.5%

$2.46 actual vs $2.40 est.

Q4 FY2024+1.9%

$2.16 actual vs $2.12 est.

Earnings call transcript

ABBV 2026Q1 call commentary.

12 segments

Operator

Operator

0.00

Good morning, and thank you for standing by. Welcome to the AbbVie First Quarter 2026 Earnings Conference Call. Today's call is also being recorded. If you have any objections, you may disconnect at this time. I would now like to introduce Ms. Liz Shea, Senior...

Elizabeth Shea

Senior Vice President, Investor Relations

0.00

Good morning, and thanks for joining us. Also on the call with me today are Rob Michael, Chairman and Chief Executive Officer; Jeff Stewart, Executive Vice President and Chief Commercial Officer; Roopal Thakkar, Executive Vice President, Research and...

Rob Michael

Chairman and Chief Executive Officer

0.90

Thank you, Liz. Good morning, everyone, and thank you for joining us. AbbVie is off to an excellent start to the year, with first quarter results exceeding our expectations across our diverse portfolio. We are delivering top-tier growth and continue to...

Jeff Stewart

Executive Vice President and Chief Commercial Officer

0.80

Thank you, Rob. I'll start with the quarterly results for immunology, which delivered total revenues of $7.3 billion reflecting impressive sales growth of $1 billion. Skyrizi total sales were $4.5 billion, up 29.2% on an operational basis, exceeding our...

Roopal Thakkar

Executive Vice President, Research and Development and Chief Scientific Officer

0.70

Thank you, Jeff. We continue to make good progress across our pipeline. I'll start with dermatology programs in immunology. As Jeff just mentioned, new data was presented at the recent AAD meeting, highlighting SKYRIZI's strong efficacy in genital and scalp...

Scott Reents

Executive Vice President and Chief Financial Officer

0.40

Thank you, Roopal. Starting with our first quarter results. We reported adjusted earnings per share of $2.65, which is $0.07 above our guidance midpoint. These results include a $0.41 unfavorable impact from acquired IPR&D expense. Total net revenues were $15...

Earnings desk view

ABBV EPS history is live.

AbbVie Inc has per-quarter EPS history available across recent reports, pairing the latest actual EPS with consensus estimates and valuation context. For real-time commentary on ABBV's next print, the news archive tracks every editorial reaction to earnings reports.

Payout history

ABBV dividend payments - recent history

Market data feed

Ex-dateAmountRecord datePayment date
$1.73
$1.73
$1.64
$1.64
$1.64
$1.64
$1.55
$1.55
$1.55
$1.55
$1.48
$1.48
$1.48
$1.48
$1.41
$1.41
$1.41
$1.41
$1.30
$1.30
$1.30
$1.30
$1.18
$1.18

Dividend safety read

ABBV pays out 329% of TTM earnings as dividends.

A payout ratio above 100% means the dividend is being funded out of cash, debt, or asset sales rather than current earnings. That usually means either earnings need to recover or the payout deserves extra scrutiny.

Frequently asked

Common questions.

When does ABBV next report earnings?

AbbVie Inc reports quarterly. Track the latest scheduled date and consensus estimate on TECHi's ABBV earnings page — updated whenever the company confirms the quarterly call.

What is ABBV's EPS?

AbbVie Inc's trailing earnings per share is approximately $2.05 based on the most recent fundamentals snapshot.

Where can I find ABBV's earnings history?

TECHi's ABBV earnings page covers the next scheduled report, the last several quarters of beats and misses, and editorial commentary tied to each release.

Did ABBV beat earnings last quarter?

Beat / miss commentary for the most recent AbbVie Inc quarter is published on the TECHi ABBV earnings page. Subscribe to the markets newsletter for the morning brief on every print.

Does ABBV pay a dividend?

Yes — AbbVie Inc (ABBV) pays a dividend with a current yield of approximately 3.08%.

What is ABBV's dividend yield?

AbbVie Inc has a forward dividend yield of approximately 3.08% based on the most recent quote.

How much does ABBV pay in dividends per share?

AbbVie Inc distributes approximately $6.74 per share annually based on the latest declared payout.

What is ABBV's payout ratio?

AbbVie Inc's payout ratio is approximately 3.29%, the share of earnings paid out as dividends. A lower ratio leaves more room for dividend growth.

Where can I track ABBV's dividend history?

TECHi's ABBV earnings and dividends page shows the live yield, payout history, ex-dividend dates, payout ratio, and dividend-safety commentary beside EPS history.

Market data is provided for informational purposes only, refreshes through configured feeds when available, and is not intended for trading purposes. Prices and fundamentals can be delayed, cached, incomplete, or revised by upstream providers. Read the data methodology or the full disclaimer.